Advanced search
Publication Cover
Expert Opinion on Drug Metabolism & Toxicology Volume 1, 2005 - Issue 3
Submit an article Journal homepage
161
Views
34
CrossRef citations to date
0
Altmetric
Review

Pharmacokinetic drug interactions with non-nucleoside reverse transcriptase inhibitors

Qing Ma University at Buffalo, Pharmacotherapy Research Center, Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, 317 Hochstetter Hall, Buffalo, NY 14260, USA. [email protected]
,
Olanrewaju O Okusanya University at Buffalo, Pharmacotherapy Research Center, Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, 317 Hochstetter Hall, Buffalo, NY 14260, USA. [email protected]
,
Patrick F Smith University at Buffalo, Pharmacotherapy Research Center, Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, 317 Hochstetter Hall, Buffalo, NY 14260, USA. [email protected]
,
Robert DiCenzo University at Buffalo, Pharmacotherapy Research Center, Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, 317 Hochstetter Hall, Buffalo, NY 14260, USA. [email protected]
,
Judianne C Slish University at Buffalo, Pharmacotherapy Research Center, Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, 317 Hochstetter Hall, Buffalo, NY 14260, USA. [email protected]
,
Linda M Catanzaro University at Buffalo, Pharmacotherapy Research Center, Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, 317 Hochstetter Hall, Buffalo, NY 14260, USA. [email protected]
,
Alan Forrest University at Buffalo, Pharmacotherapy Research Center, Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, 317 Hochstetter Hall, Buffalo, NY 14260, USA. [email protected]
&
Gene D Morse University at Buffalo, Pharmacotherapy Research Center, Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, 317 Hochstetter Hall, Buffalo, NY 14260, USA. [email protected]
 show all
Pages 473-485 | Published online: 29 Sep 2005

Citations (34)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Suyun Lei, Lizhu Hong, Cuixian Yang, Shuang Zhang, Yanyun Zhang, Shizhen Huang, Ronghui Xie, Xia Li, Qing Ma & Huiqin Li. (2019) Effect of rilpivirine on the pharmacokinetics of methadone in HIV-Infected Chinese patients. Expert Review of Clinical Pharmacology 12:6, pages 565-571.
Read now
Ramya Krishna Vadlapatla, Mitesh Patel, Durga K Paturi, Dhananjay Pal & Ashim K Mitra. (2014) Clinically relevant drug–drug interactions between antiretrovirals and antifungals. Expert Opinion on Drug Metabolism & Toxicology 10:4, pages 561-580.
Read now
Xia Liu, Qing Ma & Fujie Zhang. (2010) Therapeutic drug monitoring in highly active antiretroviral therapy. Expert Opinion on Drug Safety 9:5, pages 743-758.
Read now
Michelle D Liedtke & R Chris Rathbun. (2010) Drug interactions with antiretrovirals and warfarin. Expert Opinion on Drug Safety 9:2, pages 215-223.
Read now
Laura MacDonald, Mano Murty & Brian C Foster. (2009) Antiviral drug disposition and natural health products: risk of therapeutic alteration and resistance. Expert Opinion on Drug Metabolism & Toxicology 5:6, pages 563-578.
Read now
William W. Johnson. (2008) Cytochrome P450 Inactivation by Pharmaceuticals and Phytochemicals: Therapeutic Relevance. Drug Metabolism Reviews 40:1, pages 101-147.
Read now
Gabriele Arendt, Dominique de Nocker, Hans-Juergen von Giesen & Thorsten Nolting. (2007) Neuropsychiatric side effects of efavirenz therapy. Expert Opinion on Drug Safety 6:2, pages 147-154.
Read now

Articles from other publishers (27)

Emma Hughes, Erika Wallender, Ali Mohamed Ali, Prasanna Jagannathan & Radojka M. Savic. (2021) Malaria PK/PD and the Role Pharmacometrics Can Play in the Global Health Arena: Malaria Treatment Regimens for Vulnerable Populations. Clinical Pharmacology & Therapeutics 110:4, pages 926-940.
Crossref
Ha Young Yoon, Young Ah Cho, Jeong Yee & Hye Sun Gwak. (2020) Effects of CYP2B6 polymorphisms on plasma nevirapine concentrations: a systematic review and meta-analysis. Scientific Reports 10:1.
Crossref
Clifford G. Banda, Fraction Dzinjalamala, Mavuto Mukaka, Jane Mallewa, Victor Maiden, Dianne J. Terlouw, David G. Lalloo, Saye H. Khoo & Victor Mwapasa. (2018) Impact of Efavirenz-, Ritonavir-Boosted Lopinavir-, and Nevirapine-Based Antiretroviral Regimens on the Pharmacokinetics of Lumefantrine and Safety of Artemether-Lumefantrine in Plasmodium falciparum-Negative HIV-Infected Malawian Adults Stabilized on Antiretroviral Therapy. Antimicrobial Agents and Chemotherapy 62:11.
Crossref
Renata Buccheri & Gil Benard. (2017) Opinion: Paracoccidioidomycosis and HIV Immune Recovery Inflammatory Syndrome. Mycopathologia 183:3, pages 495-498.
Crossref
Ellen M. McDonagh, Johnathan L. Lau, Maria L. Alvarellos, Russ B. Altman & Teri E. Klein. (2015) PharmGKB summary. Pharmacogenetics and Genomics 25:7, pages 363-376.
Crossref
Christopher W. Pavitt, Tommy Rampling, Ruth Byrne, Sara Tyebally, Tom Reid & Mark Nelson. (2015) Acute porphyria precipitated by efavirenz. AIDS 29:8, pages 981-982.
Crossref
Carlos D. Malvestutto, Qing Ma, Gene D. Morse, James A. Underberg & Judith A. Aberg. (2014) Lack of Pharmacokinetic Interactions Between Pitavastatin and Efavirenz or Darunavir/Ritonavir. JAIDS Journal of Acquired Immune Deficiency Syndromes 67:4, pages 390-396.
Crossref
A. Kakuru, J. Achan, M. K. Muhindo, G. Ikilezi, E. Arinaitwe, F. Mwangwa, T. Ruel, T. D. Clark, E. Charlebois, P. J. Rosenthal, D. Havlir, M. R. Kamya, J. W. Tappero & G. Dorsey. (2014) Artemisinin-Based Combination Therapies Are Efficacious and Safe for Treatment of Uncomplicated Malaria in HIV-Infected Ugandan Children. Clinical Infectious Diseases 59:3, pages 446-453.
Crossref
Juan Carlos Sarria. (2014) Antigen negative gastrointestinal histoplasmosis in an AIDS patient. American Journal of Case Reports 15, pages 90-93.
Crossref
P. Byakika-Kibwika, M. Lamorde, J. Mayito, L. Nabukeera, R. Namakula, H. Mayanja-Kizza, E. Katabira, M. Ntale, N. Pakker, M. Ryan, W. Hanpithakpong, J. Tarning, N. Lindegardh, P. J. de Vries, S. Khoo, D. Back & C. Merry. (2012) Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults. Journal of Antimicrobial Chemotherapy 67:9, pages 2213-2221.
Crossref
F Kaestner, K Anneken, C Mostert, D Reichelt, M Rothermundt, S Evers & I W Husstedt. (2012) Depression associated with antiretroviral drug therapy in HIV: case report and overview. International Journal of STD & AIDS 23:6, pages e14-e19.
Crossref
S Nanzigu, J Eriksen, F Makumbi, S Lanke, M Mahindi, R Kiguba, O Beck, Q Ma, GD Morse, LL Gustafsson & P Waako. (2011) Pharmacokinetics of the nonnucleoside reverse transcriptase inhibitor efavirenz among HIV‐infected Ugandans. HIV Medicine 13:4, pages 193-201.
Crossref
Sandra G. Heil, Marchina E. van der Ende, Paul W. Schenk, Ilse van der Heiden, Jan Lindemans, David Burger & Ron H. N. van Schaik. (2012) Associations Between ABCB1, CYP2A6, CYP2B6, CYP2D6, and CYP3A5 Alleles in Relation to Efavirenz and Nevirapine Pharmacokinetics in HIV-Infected Individuals. Therapeutic Drug Monitoring 34:2, pages 153-159.
Crossref
R. Chris Rathbun & Michelle D. Liedtke. (2011) Antiretroviral Drug Interactions: Overview of Interactions Involving New and Investigational Agents and the Role of Therapeutic Drug Monitoring for Management. Pharmaceutics 3:4, pages 745-781.
Crossref
Aaron M. Kipp, Andrew J. Desruisseau & Han-Zhu Qian. (2011) Non-injection drug use and HIV disease progression in the era of combination antiretroviral therapy. Journal of Substance Abuse Treatment 40:4, pages 386-396.
Crossref
Michael PfallerAlan Street. 2010. Kucers' The Use of Antibiotics Sixth Edition. Kucers' The Use of Antibiotics Sixth Edition 2675 2701 .
James J. Kohler & William Lewis. 2010. Cardiotoxicity of Non‐Cardiovascular Drugs. Cardiotoxicity of Non‐Cardiovascular Drugs 313 332 .
Roberto A Andrade, Richard T Evans, Richard J Hamill, Teddy Zerai & Thomas P Giordano. (2009) Clinical Evidence of Interaction Between Itraconazole and Nonnucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients with Disseminated Histoplasmosis. Annals of Pharmacotherapy 43:5, pages 908-913.
Crossref
Michelle D Liedtke & R Chris Rathbun. (2009) Warfarin–Antiretroviral Interactions. Annals of Pharmacotherapy 43:2, pages 322-328.
Crossref
Martin S. Rhee & David J. Greenblatt. (2008) Pharmacologic Consideration for the Use of Antiretroviral Agents in the Elderly. The Journal of Clinical Pharmacology 48:10, pages 1212-1225.
Crossref
G Corona, E Vaccher, S Sandron, I Sartor, U Tirelli, F Innocenti & G Toffoli. (2007) Lopinavir–Ritonavir Dramatically Affects the Pharmacokinetics of Irinotecan in HIV Patients With Kaposi’s Sarcoma. Clinical Pharmacology & Therapeutics 83:4, pages 601-606.
Crossref
Johanna Weiss, Nicola Weis, Nahal Ketabi-Kiyanvash, Caroline H. Storch & Walter E. Haefeli. (2008) Comparison of the induction of P-glycoprotein activity by nucleotide, nucleoside, and non-nucleoside reverse transcriptase inhibitors. European Journal of Pharmacology 579:1-3, pages 104-109.
Crossref
Qing Ma, Alan Forrest, Susan L. Rosenkranz, Michael F. Para, Kevin E. Yarasheski, Richard C. Reichman & Gene D. Morse. (2007) Pharmacokinetic interaction between efavirenz and dual protease inhibitors in healthy volunteers. Biopharmaceutics & Drug Disposition 29:2, pages 91-101.
Crossref
H. L. Koo, R. J. Hamill & R. A. Andrade. (2007) Drug-Drug Interaction between Itraconazole and Efavirenz in a Patient with AIDS and Disseminated Histoplasmosis. Clinical Infectious Diseases 45:6, pages e77-e79.
Crossref
Qing Ma, Dan Brazeau, Alan Forrest & Gene D Morse. (2007) Advances in pharmacogenomics of antiretrovirals: an update. Pharmacogenomics 8:9, pages 1169-1178.
Crossref
N. M. AMPEL. (2007) Coccidioidomycosis in Persons Infected with HIV-1. Annals of the New York Academy of Sciences 1111:1, pages 336-342.
Crossref
Karen Dahri & Mary H H Ensom. (2007) Efavirenz and Nevirapine in HIV-1 Infection. Clinical Pharmacokinetics 46:2, pages 109-132.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.